Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-24-011195

President and CEO sold 19,642 shares at $4.86 ($95,460)

  • President and CEO acquired 180,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mattessich Antony C. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-03 Grant or award : show line 1 in the form +180,400 608,343 D
2024-02-05 Sale : show line 2 in the form +19,642 $4.86 $95,460 588,701 D
Open-market sales · 19,642 sh · avg $4.86 · $95,460

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-03 Grant or award : show line 3 in the form Stock Option (Right to Buy) +549,400 549,400 D
Loading xslF345X05/tm245295-1_4seq1.xml…